↓ Skip to main content

Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies

Overview of attention for article published in BMC Cancer, July 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

blogs
1 blog
patent
3 patents

Citations

dimensions_citation
149 Dimensions

Readers on

mendeley
127 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies
Published in
BMC Cancer, July 2010
DOI 10.1186/1471-2407-10-368
Pubmed ID
Authors

Milind M Javle, Rachna T Shroff, Henry Xiong, Gauri A Varadhachary, David Fogelman, Shrikanth A Reddy, Darren Davis, Yujian Zhang, Robert A Wolff, James L Abbruzzese

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 127 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 <1%
Australia 1 <1%
United Kingdom 1 <1%
Japan 1 <1%
United States 1 <1%
Unknown 122 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 25 20%
Researcher 22 17%
Student > Master 10 8%
Student > Doctoral Student 9 7%
Student > Bachelor 9 7%
Other 25 20%
Unknown 27 21%
Readers by discipline Count As %
Medicine and Dentistry 44 35%
Agricultural and Biological Sciences 16 13%
Biochemistry, Genetics and Molecular Biology 12 9%
Nursing and Health Professions 7 6%
Neuroscience 3 2%
Other 12 9%
Unknown 33 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 May 2019.
All research outputs
#3,617,248
of 22,759,618 outputs
Outputs from BMC Cancer
#834
of 8,277 outputs
Outputs of similar age
#15,242
of 94,825 outputs
Outputs of similar age from BMC Cancer
#6
of 57 outputs
Altmetric has tracked 22,759,618 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,277 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 94,825 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.